CHLORURE DE SODIUM FRESENIUS 0

DRUG7 trials

Sponsors

Institut Gustave Roussy, Hospices Civils De Lyon, Groupement De Cooperation Sanitaire Ramsay Generale De Sante Pour L'enseignement Et La Recherche, Phaxiam Therapeutics, Centre Hospitalier Universitaire Amiens Picardie

Conditions

Foot surgeryHand SurgeryHip or Knee prosthetic joint infection due to Staphylococcus aureusadverse kidney events during septic shockchronic common low back painchronic hemodialysis patients (for more than 3 months) with no residual diuresis (<100 mL/day).knee or hip prosthetic joint infection (PJI) due to Staphylococcus aureuspatients with a positive status for molecular residual disease (MRD) [MRD (+)] 2 to 5 months after the end of standard end of standard curative treatment

Phase 2

Evaluation of the benefit and safety of Localized Tissue Hydration (LTH) in the management of chronic common low back pain: Non-randomized single-center phase II study

Active, not recruitingCTIS2024-510625-25-00

Groupement De Cooperation Sanitaire Ramsay Generale De Sante Pour L'enseignement Et La Recherchechronic common low back pain

Start: 2024-11-14Target: 29Updated: 2025-02-28

PhagoDAIR I : A Pilot, Multicenter, Randomized, Non Comparative, Double-Blind Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus Treated with DAIR and Antibiotic Therapy.

CompletedCTIS2024-516207-17-00

Phaxiam Therapeuticsknee or hip prosthetic joint infection (PJI) due to Staphylococcus aureus, with the indication of DAIR and Suppressive Antibiotics Therapy (SAT)

Start: 2022-06-15End: 2025-04-08Target: 29Updated: 2025-03-24

CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins

RecruitingCTIS2023-510406-41-00

Hospices Civils De Lyonchronic hemodialysis patients (for more than 3 months) with no residual diuresis (<100 mL/day).

Start: 2025-09-22Target: 12Updated: 2025-06-04

A Phase II Proof of Concept Multicenter, Randomized, Double-Blind Study to assess the safety and efficacy of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus Treated by DAIR

Not yet recruitingCTIS2024-516555-40-00

Phaxiam TherapeuticsHip or Knee prosthetic joint infection due to Staphylococcus aureus

Target: 51Updated: 2025-03-24

Phase 3

tislelizUMaB in canceR patients with molEcuLar residuaL disease (UMBRELLA)

RecruitingCTIS2023-503316-33-00

Institut Gustave Roussypatients with a positive status for molecular residual disease (MRD) [MRD (+)] 2 to 5 months after the end of standard end of standard curative treatment

Start: 2024-09-26Target: 717Updated: 2025-10-21

Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study.

CompletedCTIS2024-517055-13-00

Centre Hospitalier Universitaire Amiens Picardieadverse kidney events during septic shock

End: 2025-09-11Target: 310Updated: 2025-06-02

Phase 4

Evaluation of the effect of adrenalized lidocaine with or without bicarbonate on early postoperative recovery in ambulatory hand and foot surgery with WALANT: A Single-centre prospective randomised double-blind non-inferiority study.

Not yet recruitingCTIS2024-519650-36-00

Centre Hospitalier Universitaire De NimesFoot surgery, Hand Surgery

Target: 150Updated: 2025-09-02